3SBio will grant Pfizer exclusive global rights, not including China, to develop, manufacture and commercialize SSGJ-707, a ...

3SBio will receive an upfront payment of $1.25B and is eligible to receive milestone payments associated with certain development, regulatory and commercial milestones up to $4.8B as well as tiered ...

The World Health Organization's member countries have approved an agreement to better prevent, prepare for and respond to ...

Members of the World Health Organization adopted a landmark agreement on Tuesday on how to prepare for future pandemics ...

Pfizer just penned a $6 billion licensing deal with China's 3SBio to develop and commercialize a cancer drug, SSGJ-707. The ...

Countries can’t agree on how to share and compensate for pathogen data Global pandemic treaty nears adoption, but key ...

At a recent gathering, experts in the Swiss biotech and pharma sector underscored the power of international alliances.

Pfizer beats EPS estimates for the 12th quarter. Explore PFE's oncology success, cost-cutting impact, and why it's rated a ...

A top court on Wednesday ruled that the European Commission had failed the transparency test by declining to release text ...